Novoxel and GPOphtho Partner to Expand Access to Dry Eye and Aesthetic Treatments
Editorial
1 minute
Novoxel and GPOphtho Partner to Expand Access to Dry Eye and Aesthetic Treatments
Novoxel Inc. and GPOphtho have announced a strategic partnership to bring Novoxel’s FDA-cleared Tixel® devices, including the rapid, non-invasive Tixel i® for dry eye and aesthetic treatments, to eyecare providers nationwide—offering discounted pricing and innovative, consumable-free technology.